In a mouse model of heart failure, blocking VEGF-C/VEGFR-3-mediated signals (AKT/ERK1/2, calcineurin A/NFATc1/FOXc2 and CX43) resulted in decreased cardiac lymphangiogenesis and increased cardiac dysfunction [59]. This evidence concerns the gene MAPK3 and heart failure.